Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, India. It was founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer. The company initially sold its products in India, Russia, and Africa. The company went public in India in 1999, and used some of the proceeds to build its first research facility. Saldanhas son Glenn took over as CEO in 2001, having returned to India after working at PricewaterhouseCoopers. Glenmark Pharmaceuticals is a leading, research-based global pharmaceutical company that is discovering advanced therapies for a new world. It is creating centers of excellence in dermatology, oncology, and respiratory segments. The company is committed to enriching lives and making a difference to patients all over the world. It constantly strives to find new ways that pave the way for a healthier tomorrow.